2007-12-01
Dendritic cells in asthma and COPD: opportunities for drug development
Publication
Publication
Current Opinion in Immunology , Volume 19 - Issue 6 p. 701- 710
The lung contains many subsets of dendritic cells that are distributed in various anatomical compartments. In homeostatic conditions, a fine-tuned balance exists between plasmacytoid and myeloid dendritic cells necessary for maintaining tolerance to inhaled antigen and avoiding overt inflammation. These subsets of DCs also play important roles in establishment of airway inflammation seen in asthma and chronic obstructive pulmonary disease. Based on these new insights on airway DC biology, several approaches that interfere with DC function show potential as new intervention strategies for these ever increasing diseases.
Additional Metadata | |
---|---|
doi.org/10.1016/j.coi.2007.09.003, hdl.handle.net/1765/36348 | |
Current Opinion in Immunology | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Kool, M., & Lambrecht, B. (2007). Dendritic cells in asthma and COPD: opportunities for drug development. Current Opinion in Immunology (Vol. 19, pp. 701–710). doi:10.1016/j.coi.2007.09.003 |